BUZZ-Sino Biopharm climbs most in five weeks on cancer drug development progress
Reuters
Feb 09
BUZZ-<a href="https://laohu8.com/S/01177">Sino Biopharm</a> climbs most in five weeks on cancer drug development progress
** Shares of Sino Biopharmaceutical1177.HK climb 3.7% to HK$6.72, on course for the biggest one-day pct rise since January 7
** Stock hits highest since January 30 on its fifth straight session of gain
** Company said its unit's drug has completed patient enrollment in its Phase III registrational clinical trial for treatment of metastatic gastric and gastroesophageal junction adenocarcinoma
** YTD, stock up 7.6%, Hang Seng Biotech Index .HSBIO up 9.4%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.